Evaluation of allele frequencies in the PADI4 gene and anti-cyclic citrullinated peptide antibodies of patients with rheumatoid arthritis in a Japanese population

被引：4
|
作者：
Suzuki, M.
Miyagi, J.
Kuribayashi, M.
Negishi, E.
Ueno, K.
Moriya, H.
机构：
[1] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Geriatr Pharmacol, Chuo Ku, Chiba 2608670, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷 / 10期
关键词：
D O I：
10.1136/ard.2006.052431
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1399 / 1400
页数：2
相关论文
共 50 条
  • [31] Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis
    Moghimi, Jamileh
    Ghorbani, Raheb
    Hasani, Farnaz
    Sheikhvatan, Mehrdad
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (03) : 601 - 605
  • [32] Effect of infliximab therapy on anti-cyclic citrullinated peptide antibodies levels in patients with rheumatoid arthritis
    Kyriazis, NC
    Papalopoulou, M
    Balla, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 172 - +
  • [33] Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
    Hromadnikova, I
    Stechova, K
    Vavrincova, P
    Hridelova, D
    Houbova, B
    Voslarova, S
    Nekvasilova, H
    Vavrinec, J
    AUTOIMMUNITY, 2002, 35 (06) : 397 - 401
  • [34] Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis
    Böckelmann, R
    Gollnick, H
    Bonnekoh, B
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1701 - 1702
  • [35] Diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with etanercept
    Drynda, S.
    Wollenberg, H.
    Khne, C.
    Polter, J.
    Kekow, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A21 - A22
  • [36] THE DIAGNOSTIC UTILITY OF ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR IN RHEUMATOID ARTHRITIS
    Eldin, A. Radr
    Mobasher, S. A.
    Hegazy, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 898 - 898
  • [37] Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis
    Keskin, Goksal
    Inal, Ali
    Keskin, Dilek
    Pekel, Aysel
    Baysal, Ozan
    Dizer, Ufuk
    Sengul, Ali
    PROTEIN AND PEPTIDE LETTERS, 2008, 15 (03): : 314 - 317
  • [38] Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, brucellar arthritis and Behcet's disease
    Aridogan, Buket Cicioglu
    Cetin, Emel Sesli
    Yildirim, Mehmet
    Kaya, Selcuk
    Ceyhan, Ali Murat
    Demirci, Mustafa
    Savas, Serpil
    Ural, Onur
    Akkus, Selami
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2011, 5 (19): : 2975 - 2979
  • [39] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [40] Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis
    Matsui, Toshihiro
    Shimada, Kota
    Ozawa, Naoko
    Hayakawa, Hiromi
    Hagiwara, Futoshi
    Nakayama, Hisanori
    Sugii, Shoji
    Ozawa, Yoshinori
    Tohma, Shigeto
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (12) : 2390 - 2397
12345